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Genome-wide Identification and Characterization
of Fixed Human-Specific Regulatory Regions
Davide Marnetto,1,3 Ivan Molineris,1,3 Elena Grassi,1 and Paolo Provero1,2,*
Changes in gene regulatory networks are believed to have played an important role in the development of human-specific anatomy and
behavior. We identified the human genome regions that show the typical chromatin marks of regulatory regions but cannot be aligned
to other mammalian genomes. Most of these regions have become fixed in the human genome. Their regulatory targets are enriched in
genes involved in neural processes, CNS development, and diseases such as autism, depression, and schizophrenia. Specific transposable
elements contributing to the rewiring of the human regulatory network can be identified by the creation of human-specific regulatory
regions. Our results confirm the relevance of regulatory evolution in the emergence of human traits and cognitive abilities and the
importance of newly acquired genomic elements for such evolution.Introduction
Empirical evidence and theoretical arguments suggest that
the rewiring of gene regulatory networks plays an impor-
tant role in the evolution of metazoan anatomy.1 The set
of targets of a trans-acting regulatory element can evolve
by modifying the cis-regulatory regions (RRs) to which it
binds while leaving the trans element unchanged.
Such arguments are supported by a large body of exper-
imental evidence demonstrating, in specific cases, how
the evolution of anatomical traits is triggered by the
addition or subtraction of targets of a trans-acting regulato-
ry element.2–7 The availability of the complete genome
sequence of many organisms has recently allowed the
investigation of these issues at a genome-wide scale.
Some of these studies specifically concerned regulatory
evolution in the human lineage.8–12 Given a RR in the
human genome, these studies variously relied on sequence
alignments to identify the orthologous region in other
mammals and then proceeded to analyze patterns of
divergence and/or variation in the sequence,9,10 the profile
of binding affinities for transcription factors (TFs),8,11 or
chromatin states.12
On the other hand, genomic regions that have appeared
de novo in the human genome, for example, through the
insertion of transposable elements (TEs), or that have
diverged so extensively since the origin of humans to
become unrecognizable by alignment algorithms have
not been explored in these studies, even though in princi-
ple they could have important regulatory roles. For
example, the evolution of CTCF (MIM 604167) binding
in mammals was recently shown13 to be largely driven
by TEs.
We thus set out to investigate those human genome
regions that, on the one hand, show evidence of an active
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Thother mammals. We called these regions human-specific
RRs (HSRRs), and we investigated their variation in human
populations, the evolutionary mechanisms at their origin,
and the TFs that bind them. Moreover, we analyzed the
functional characterization of their putative gene targets
and their involvement in genetic diseases.Material and Methods
Identification of HSRRs
We defined RRs as the human genome regions (obtained from the
UCSC Genome Browser, release hg19) assigned by Ernst et al.14 to
the following classes: (1) active promoters, (2) weak promoters, (3)
poised promoters, (4) strong enhancers, (5) strong enhancers, (6)
weak enhancers, (7) weak enhancers, and (8) insulators. We
grouped these classes intopromoters (classes 1–3), strongenhancers
(classes 4 and 5), weak enhancers (classes 6 and 7), and insulators
(class 8). The cell lines analyzed by Ernst et al.14 are H1 embryonic
stemcells (ESCs), erythrocytic leukemia (K562) cells, B-lymphoblas-
toid (GM12878) cells, hepatocellular carcinoma (HepG2) cells,
human umbilical vein endothelial cells (HUVECs), skeletal muscle
myoblasts (HSMMs), normal human lung fibroblasts (NHLFs),
normal epidermal keratinocytes (NHEKs), andmammary epithelial
cells (HMECs). We generated a meta-cell line, ALL, by merging the
RRs of the same type from the cell lines analyzed.
A RR was considered conserved (CRR) if any portion of the
region could be aligned to the genome of one or more of the
following species (the UCSC Genome Browser version is in
parentheses): A. melanoleuca (ailMel1), B. taurus (bosTau4),
C. familiaris (canFam2), C. jacchus (calJac3), C. porcellus (cavPor3),
E. caballus (equCab2), G. gorilla (gorGor3), M. mulatta (rheMac2),
M. musculus (mm9), N. leucogenys (nomLeu1), P. pygmaeus abelii
(ponAbe2), P. troglodites (panTro3), and R. rnorvegicus (rn4). All
other RRs were considered HSRRs. We used the precomputed
net alignments downloaded from UCSC Genome Browser to
compare the human genome (hg19) with those reported above.
Adjacent RRs belonging to the same RR class, cell line, or
human-specificity status were merged.urin, 10126 Turin, Italy; 2Center for Translational Genomics and Bioinfor-
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The same pipeline was applied to data on DNase hypersensitive
sites (DHSs): we selected all DHS peaks collected in the ENCODE
Project and whose karyotype was flagged as ‘‘normal.’’ For DHS
data, we defined a single RR class (‘‘open’’). To these we added
DHS data from human fetal brain obtained by the NIH Roadmap
Epigenomics Mapping Consortium.15 These were downloaded
from the Gene Expression Omnibus (samples GSM595913,
GSM595920, GSM595922, GSM595923, GSM595926, and
GSM595928) as .bam files, on which peaks were detected with
MACS16 with default parameters.Definition of a Neutral Control
A putatively neutral subset of the genome was defined by the
removal of (1) regions considered open according to Ernst et al.14
(i.e., classes1–11) inanyENCODEcell line, (2)DHSs fromENCODE,
and (3) sequencegapsderived fromtheUCSCGenomeBrowser. The
neutral control was composed of regions belonging to this neutral
genome; for each RR, we included in the control a region of the
same length, completely included in the neutral genome, as close
as possible to the RR. The neutral control regions were divided
into HSRRs and CRRs and analyzed in the same way as the RRs.Analysis of Intraspecies Variation of HSRRs
We used variation data inferred by exome and full genome
sequencing of 1,092 individuals from the 1000 Genomes
Project.17 To maximize the specificity, the 1000 Genomes Project
applied a strict procedure to define regions of structural variants
(SVs). Given that we were mostly interested in high sensitivity to
ensure that the regions we studied could be considered fixed in
thehumangenome,we also considered low-quality, nongenotyped
SVs absent in the integrated variant call format. Variation was clas-
sified into two classes: SNPs, including indels and small polymor-
phisms, and SVs, including long deletions or insertions (including
those due to mobile elements and tandem duplications). Each RR
identifiedbyErnstet al.14was classifiedas ‘‘fixed’’ if itdidnotoverlap
a SVor ‘‘variant’’ otherwise. Adjacent RRs belonging to the same RR
class, cell line, human-specificity status, or SV status were merged.
To compare SNP density, heterozygosity, and Tajima’s D of fixed
HSRRs (FHSRRs) to their conserved counterparts while controlling
for potential confounders,18–20 we used a linear model with SNP
density, heterozygosity, or Tajima’s D, respectively, as the depen-
dent variable. The independent variables were GC content, CpG
content, CpG island overlap, accessibility to sequencing, and
human-specificity status. To build this model, we broke each
region into 200 bp fragments to avoid overweighing smaller
regions. Accessibility was defined as the overlap with ‘‘strict’’
regions from the 1000 Genomes ‘‘Ph1 Accsbl’’ track taken from
the UCSC Genome Browser. The sign of the fitted coefficient
of the human-specificity status then revealed whether (given
all the same confounding factors) SNP density or heterozygosity
was higher (positive sign) or lower (negative) than in the CRRs.
We evaluated the dispersion of the coefficients with a resampling
procedure: for each resampling step, we picked a random subset of
CRRs as large as the set of HSRRs, and we fit a linear model to the
data set thus obtained.We repeated the procedure 1,000 times and
represented the distribution of the 1,000 values of the coefficient
as a box plot in Figures 2B–2D.Functional Analysis with GREAT
We used the ‘‘createRegulatoryDomains’’ program from the
Genomic Regions Enrichment of Annotations Tool (GREAT)21 to40 The American Journal of Human Genetics 95, 39–48, July 3, 2014associate a regulatory domain with each Ensembl protein-coding
gene (with the default ‘‘basalPlusExtension’’ rule). We then associ-
ated each RR with a gene if the RR overlapped the corresponding
regulatory domain. In this way, we obtained for each cell line
and RR class a list of genes associated with FHSRRs; we tested
this list for functional enrichment against a universe defined as
all genes associated with a fixed RR (HSRR or CRR) of the same
type active in the same cells. We assessed functional enrichment
by using the GOstats22 and DOSE Bioconductor packages with
default parameters for Gene Ontology (GO) and Disease Ontology,
respectively. We performed our own enrichment analysis instead
of using GREAT to be able to perform a gene-based (rather than
region-based) enrichment analysis while specifying a universe.
In Figure 3, we used the GOSemSim package23 to remove redun-
dant GO terms, including all terms with a semantic similarity24
higher than 0.7 with a term with a more significant p value. We
obtained NPC-specific genes from Table S1 in Xie et al.25 and
performed enrichment analysis with the gene-region associations
generated by GREAT.
Overlap with ASD-Related CNVs
We obtained data about copy-number variations (CNVs) in autism
spectrum disorders (ASDs) from two different papers: Pinto et al.26
(Table S8: ASD_cases_European) and Sanders et al.27 (Table S8). We
converted the UCSC hg18 genomic CNV coordinates used in these
papers to UCSC hg19 coordinates. We performed independent
Fisher’s exact tests to evaluate the enrichments of (1) CNVs over-
lapping FHSRRs with respect to all fixed RRs in each individual
data set and (2) CNVs overlapping FHSRRs with respect to all fixed
RRs in both data sets. For this analysis, we merged RRs of different
cell lines into a single list.
Analysis of TF Binding
We used chromatin-immunoprecipitation-sequencing (ChIP-seq)
peak data from the ENCODE/HAIB, ENCODE/UChicago, and
ENCODE/Sydh tracks downloaded from the UCSC Genome
Browser. A TF T was considered bound to RR R if a peak of T
overlapped any portion of R. For each TF and cell line, we used a
Fisher’s exact test to evaluate the enrichment of TF binding in
FHSRRs in comparison to the enrichment in all fixed RRs.
The Role of TEs
We downloaded coordinates for TEs from the UCSC RepeatMasker
track (hg19). For each R, we associated the transposon T if R and T
overlapped and there was only one overlapping transposon. If
there were more overlapping transposons, we chose the one
with the longest overlap. We used a Fisher’s exact test to evaluate
enrichments of each repeat type (e.g., MIR3), family (e.g., MIR),
and class (e.g., SINE) in FHSRRs with respect to enrichments in
all fixed RRs overlapping any TE.
Software
All analyses were performed with software available from
Bioconductor,28 BEDTools,29 and GREAT21 (see Web Resources).Results
HSRRs
Our starting point was classifying HSRRs on the basis of
chromatin marks in nine cell lines obtained by Ernst
Gm12878 K562
100
200
300
400
500
600
700
800
900
0
Insulator
Promoter
Strong Enhancer
Weak Enhancer
Open
0.0%
0.2%
0.4%
0.6%
0.8%
1.0%
1.2%
H1 ESC HepG2 HMEC HSMM HUVEC NHEK NHLF
Figure 1. HSRRs
Upper histogram: the size of HSRRs in thousands of base pairs for
the various cell types and RR classes. The first four classes were
obtained from the data of Ernst et al.,14 whereas the ‘‘open’’ class
refers to DHS data.
Lower histogram: the human-specific fraction of each class of
regulatory DNA. H1 ESCs, HepG2 cells, and K562 cells showed a
higher number of HSRRs in both absolute and relative terms.et al.14 Independently for each cell line, the authors
divided the genome into 15 classes, eight of which were
of regulatory significance. We merged some of their classes
to obtain four classes of RRs: insulators, promoters, strong
enhancers, and weak enhancers.
We defined a HSRR as one that does not appear in
genome-wide alignments with any of 13 mammalian ge-
nomes (listed in theMaterial andMethods), including those
of six primates and four apes. We used the Net alignments
provided by the UCSC Genome Browser. Figure 1 shows
the genomic portion occupied by HSRRs that we found in
each of the nine investigated cell lines in both absolute
terms and as a fraction of the regulatory genome.
Intraspecies Variation of HSRRs
To begin studying the functional relevance of the HSRRs,
we investigated their patterns of variation within human
populations by using data from the 1000 Genome
Project.17 We classified variation in two large classes:
(1) SNPs, including SNPs and small indels, and (2) SVs,
including long deletions or insertions, insertions due to
mobile elements, and tandem duplications.
SVs appeared to be more common in HSRRs than in
other RRs, as might be expected given the young evolu-
tionary age of these regions (see Figure 2A). However, for
all RR classes and all cell lines, most HSRRs did not overlap
any known SV. In the following sections, we will focus on
these SV-free HSRRs, which we refer to as FHSSRs, given
that these are the ones most likely to have a functional
role. The number of FHSSRs found in the nine cell lines
is shown in Table 1. Table S1, available online, contains
the list of all FHSRRs for each cell line. As a negative set,
we defined a putatively neutral control made of regionsThthat are not regulatory in any cell line and are located in
the vicinity of a FHSSR.
We compared the rate of intraspecies variation in
FHSRRs to that in fixed RRs that are not human specific
by looking at their SNP density and heterozygosity (Figures
2B and 2C). Using a linear model to control for potential
confounding factors18–20 (such as GC content, CpG
content, and DNA accessibility), we found that human-
specific promoters had higher SNP density and heterozy-
gosity than their conserved counterparts, suggesting that
the selective pressure on human-specific promoters is
weaker than that on conserved ones. On the other hand,
both strong and weak enhancers showed lower SNP
density and heterozygosity than did conserved enhancers,
instead suggesting stronger negative selection. Finally,
human-specific insulators showed higher SNP density but
lower heterozygosity than did conserved ones. Note that
Ward et al.18 reported higher SNP density and hetero-
zygosity in nonconserved RRs than in CRRs. However,
our FHSRRs are a different (and much smaller) set of
regions than the nonconserved ones in Ward et al.,18 and
their nonconserved regions are actually included in our
conserved (i.e., nonhuman specific) regions (at least
conceptually, given that the genome-wide alignments we
used do not coincide with those used by Ward et al.).
It is difficult to interpret these results in terms of selec-
tive pressure alone; indeed, the putatively neutral
human-specific controls also showed lower SNP density
and heterozygosity than did the conserved ones, possibly
because the factors included in our linear model did not
completely capture a difference in mutation rate between
HSRRs and CRRs. Therefore, we analyzed a quantity that
has a direct interpretation in terms of selective pressure,
namely Tajima’s D.30 The expected value of D is 0 for the
null hypothesis of neutrality; negative values of D indicate
purifying selection or population expansion, whereas
positive values indicate balancing selection or a decrease
in population size.
Overall, the D values were significantly less than 0 for all
classes of RRs, particularly HSRRs (Figure 2E; p values from
1.64 3 1010 for promoters to 4.52 3 1044 for weak
enhancers, Wilcoxon signed-rank test). This implies that
HSRRs are under selective pressure. Moreover, for all classes
of FHSRRs, the mean D values were more negative than
those of the respective controls, even though this reached
statistical significance only for insulators (p¼ 4.563 104,
Mann-Whitney U test) and strong enhancers (p ¼ 2.12 3
104). When comparing the D values of HSRRs and CRRs
(Figure 2D) while controlling for the same confounding
factors considered for SNP density and heterozygosity, we
saw that for insulators and strong enhancers, HSRRs had
a smaller D, whereas the opposite was true for promoters
and weak enhancers.
Regulatory Targets
Overall, the results of the previous section neither exclude
nor prove that FHSRRs are functional.We thus investigatede American Journal of Human Genetics 95, 39–48, July 3, 2014 41
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Figure 2. Variation of HSSRs
(A) SVs identified in the 1000 Genomes
Project were more prevalent in each
class of HSRRs than in their conserved
counterparts.
(B–D) Comparison of SNP density (B),
heterozygosity, and (C) Tajima’s D be-
tween fixed HSRRs and their conserved
counterparts. The box plots show the coef-
ficient of the human-specificity status in a
linear model including CG content, CpG
content, overlap with annotated CpG
islands, and DNA accessibility as indepen-
dent variables. A positive or negative
coefficient implies that when all other
variables were the same, the independent
variable (SNP density or heterozygosity)
was higher or lower, respectively, in HSRRs
than in CRRs. For each class of RR, we also
show the corresponding neutral control.
The distribution of the coefficients in the
box plot was obtained by resampling.
All coefficients are significantly different
from 0 (p < 0.05).
(E) Distribution of Tajima’s D. For each
class of RR, we show CRRs and HSRRs
and the corresponding neutral controls.their functional relevance by examining their target genes,
particularly their functional annotation. We reasoned that
overrepresentation of some functional categories in the
regulatory targets of FHSRRs would strongly argue for their
biological relevance.
We used GREAT21 to associate FHSRRs to putative gene
targets. We computed all enrichments by comparing the
targets of fixed HSRRs active in a given cell line to all the
targets of the same type of RRs active in the same cell
line. Weak enhancers active in human ESCs showed the
most significant enrichments: the significantly enriched
terms are shown in Figure 3, where redundant terms
were removed as described in the Material and Methods.
Overall, they showed a strong enrichment of genes
involved in neural processes and development. Several of
these enrichments were also found in the human-specific
promoters active in ESCs, in which rather specific
terms, such as ‘‘serotonin receptor activity,’’ were also42 The American Journal of Human Genetics 95, 39–48, July 3, 2014enriched. The functional enrichment
of human-specific promoters was
especially significant given that this
is the class of FHSRRs that appear to
be under the weakest selective pres-
sure from the analysis of intraspecies
variation (Figure 2). Complete enrich-
ment results are included in Table S2.
Also, the analysis of enrichment in
Disease Ontology31 terms gave the
most significant results for FHSRRs
active in ESCs. Results for weak
enhancers are shown in Figure 3, and
they confirm the strong neural charac-
terization of the target genes. Thesetermswere also enriched inhuman-specificpromoters active
inESCs, suggesting thatmanyhuman-specificpromoters are
functional notwithstanding their relatively high variability,
shown in Figure 2. These results prompted us to investigate
whether FHSRRs are involved in theCNVsknown tobe asso-
ciated with personality diseases, specifically autism.26,27
However, FHSRRsdidnot showa stronger enrichment indis-
ease-related CNVs than in nonregulatory HSRRs (Figure S1).
Otherdiseasesnotdirectly linked to theCNSandenriched in
HSRR targets include obesity (enriched in promoters, 13
genes), pancreatitis (promoters, six genes), and abortion
(promoters, six genes). Other cell lines gave, in general, a
much smaller number of enrichments, often of difficult
interpretation. Complete results are shown in Table S3.
FHSRRs are strongly overrepresented in the X chromo-
some (see Figure S2), possibly because of its enrichment
of repeated elements.32 However, the GO and Disease
Ontology enrichments we found above were mostly
Table 1. Numbers of FHSRRs
Cell Line Origin
Number of FHSRRs
Insulators Promoters Strong Enhancers Weak Enhancers
Gm12878 lymphoblastoid cells 66 19 11 114
H1 ESC embryonic stem cells 78 535 173 1,146
HepG2 liver carcinoma cells 49 135 78 1,103
HMEC mammary epithelial cells 49 8 23 146
HSMM skeletal muscle myoblasts 51 13 17 127
HUVEC human umbilical vein endothelial cells 47 7 12 73
K562 leukemia cells 78 413 62 1,072
NHEK epidermal keratinocytes 78 14 28 179
NHLF lung fibroblasts 88 2 7 80
The nine cell lines studied by Ernst et al.14 are shown with the corresponding numbers of FHSRRs in the four RR classes.unchanged when we restricted the analysis to autosomes
(Table S4 and S5).
These functional enrichments provide strong evidence of
the functional relevance of FHSRRs and suggest that they
play a role in the very early development of the CNS. We
thus hypothesized that the target genes of FHSRRs could
be expressed inneural progenitor cells (NPCs).We obtained
a list of genes specifically expressed in NPCs from a recent
RNA-sequencing experiment,25 and we compared this listlung cell differentiation
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The GO and Disease Ontology terms enriched in targets of human-sp
sents the number of targets, and the shaded part is the number of
Benjamini-Hochberg procedure. We show all terms with Q < 0.05 (
removed as described in the Material and Methods.
Thto the putative targets of FHSRRs. We found that there
was indeed a strong overrepresentation of NPC-specific
genes among the targets of human-specificweak enhancers
and promoters active in ESCs (weak enhancers: 94 genes,
p¼2.53107; promoters: 52 genes, p¼1.43104; Fisher’s
exact test). The NPC-specific genes that are targets of
FHSRRs are shown in Table S7. However, human-specific
promoters active in K562 cells were also enriched in NPC-
specific genes (45 genes, p ¼ 6.5 3 105).metallopeptidase activity
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Figure 4. Examples of FHSSRs
Two FHSRRs (indicated by the blue shade) and the genomic landscape around them (which includes putative targets) as depicted by the
UCSC Genome Browser. The tracks represent (top to bottom) base position, RefSeq genes, Broad ChromHMM (RRs), Primate Chain/
Net alignment, Placental Chain/Net alignment, and RepeatMasker. Color coding for Broad ChromHMM is as follows: yellow, weak
enhancer; orange, strong enhancer; red, promoter; light red, weak promoter; purple, poised promoter; and blue, insulator.
(A) SRGAP1, a gene whose expression in humans is shifted from that in other primates.
(B) HTR2C, encoding a serotonin receptor involved in several mental illnesses.Figure 4 shows two examples of FHSRRs near SRGAP1
(MIM 606523) and HTR2C (MIM 312861). SRGAP1, whose
expression in the cerebellum is different in humans than
in other primates,33 is involved in the early development
of the human fetal neocortex.34 HTR2C encodes a seroto-
nin receptor that has been involved in several mental
disorders, including schizophrenia, bipolar disorder, and
major depression.35 Notably, HTR2C was recently sug-
gested to show human-specific patterns of X-chromo-
some-inactivation status.36
These results suggest that the appearance of new
sequence with regulatory potential in the human genome
contributed to many of the phenotypic differences that44 The American Journal of Human Genetics 95, 39–48, July 3, 2014most prominently separate us humans from our closest
relatives, particularly those differences concerning the
development and physiology of the CNS.
Using DHSs to Define RRs
Amajor limit of the previous analysis is that it was based on
a limited number of cell lines for which chromatin data are
available. To widen the scope of our analysis, we turned to
DHSs, which are available for a wide variety of cell lines and
primary tissues, as an alternative definition of active regula-
tory sequences. We considered all DHS data available in
ENCODE and whose karyotype is flagged as ‘‘normal.’’
The list of DHS data used is provided in Table S7.
Because DHS data are also available for the cell lines used
in the previous analysis, we first asked what fraction of the
various classes of RRs are represented in DHS data. In gen-
eral, DHSs tend to cover a smaller fraction of the genome
than do chromatin-based RRs. Moreover, as expected, pro-
moters are overrepresented in DHSs, whereas enhancers
are underrepresented (Figure S3). This leads to a decrease
in statistical power to detect the functional signals dis-
cussed above.
However, the functional characterization of FHSRRs
expressed in ESCs is confirmed by DHS data: the most sig-
nificant GO Biological Process term is indeed ‘‘neurogene-
sis’’ (19 genes). Cells and tissues other than ESCs show rela-
tively few enrichments. A potentially interesting result is
the overrepresentation of ‘‘transferase activity, transferring
hexosyl groups’’ in hepatocytes (six genes: ALG10 [MIM
603313], ALG10B, B4GALT7 [MIM 603313], FUT3 [MIM
111100], FUT5 [MIM 136835], and FUT6 [MIM 136836]).
Given that FHSRRs seem to be involved specifically in
the development of the CNS, we obtained DHS data from
six fetal brain samples from the NIH Roadmap Epige-
nomics Mapping Consortium15,37 and performed the
same analysis. The enrichment of ‘‘axon extension’’ was
independently found in three different samples, even
though it was based (in all three samples) only on three
genes (FOXD4 [MIM 601092], FOXD4L1 [MIM 611084],
and MAP1B [MIM 157129]). In contrast, DHS data from
adult brain did not lead to any GREAT enrichment, again
suggesting that HSRRs play their most important role in
the development, rather than in the adult physiology, of
the CNS.
TF Binding
We took advantage of the large collection of ChIP-seq
experiments generated by the ENCODE Project38 to inves-
tigate whether specific TFs bind the FHSRRs. When joining
all cell lines together, we found significant enrichment
(false-discovery rate [FDR] < 0.05) of six TFs. The most sig-
nificant enrichment was found for NR2F2, which binds
617 out of 2,495 human-specific weak enhancers and 83
out of 359 human-specific strong enhancers. This TF, also
known as COUP-TFII, is particularly involved in the migra-
tion of neurons during brain development.39,40 The liver-
specific TF FOXA1 was also enriched in human-specific
weak enhancers (376 bound) and promoters (235 bound
out of 815 human-specific promoters). Human-specific
insulators were enriched with binding sites for ZBTB33 (a
transcriptional repressor, also known as Kaiso, that inter-
acts with CTCF and negatively regulates the insulator
activity of the latter41) and the homeobox TF SIX5. Finally,
weak enhancers were enriched in TAF1 binding, suggesting
significant transcriptional activity, which might be related
to the fact that many of these regions originate as retro-
transposons (see below). Complete results are available in
Table S9.
When analyzing individual cell lines, we considered
only the peaks derived from ChIP-seq experiments per-Thformed in the same cell line. Complete results are available
in Tables S10, S11, S12, S13, and S14. For ESCs, the stron-
gest enrichment was for Pol2 and TAF1, suggesting that
the transcriptional activity of FHSRRs is especially notable
in these cells.The Role of TEs
TEs are important sources of genomic evolution.42 We
sought to determine which TEs play a role in the appear-
ance of FHSRRs. Specifically, we considered the RRs
overlapping each TE class, and we looked at which of
such classes are significantly enriched in FHSRRs. Note
that an overall enrichment of TEs in FHSRRs is expected
because of how FHSRRs are defined; here, we restricted
the analysis to RRs overlapping a TE to determine which
classes of TEs are associated with FHSRRs.
Overall, considering all cell lines and RR classes, we
found 199 significant overlaps at a 5% FDR and 25
different classes of repeated elements. The significant
results for ESCs are shown in Table 2, and complete results
are available in Table S14. Of particular interest is the
appearance of HERVH and LTR7, given that these elements
were recently shown25 to play an important role in the
regulation of long noncoding RNAs in human ESCs. Our
results suggest that this phenomenon might be largely
human specific.Discussion
By integrating the genomic sequences of a large number of
mammals and chromatin-state data on human cell lines,
we were able to identify those human genome portions
that were acquired after the split from our closest relatives
and that perform a regulatory function in our genome.
Many of these regions originated from mobile DNA
elements, an extremely efficient vehicle for the rewiring
of regulatory networks. Most of these regions have been
fixed in the human genome, and their functional rele-
vance is suggested by the strong functional characteriza-
tion of their putative targets.
As originally suggested by King and Wilson,43 the diver-
gence in coding sequence between human and chim-
panzee seems too low to account for the extensive
differences in cognitive abilities, behavior, andmetabolism
between the two species. It is therefore natural to postulate
that a relevant part of these differences is explained by dif-
ferences in gene regulation rather than in gene products.
HSRRs have most likely played a role in generating such
differences, as shown by the enrichment of genes involved
in neural development and psychiatric diseases, such as
bipolar disorder, schizophrenia, and autism.
Such strong functional characterization of HSRRs is to be
contrasted with their rather weak selective pressure at the
sequence level: this suggests a model in which regulatory
rewiring is more effectively performed by the relocation
of whole regulatory sequences to new genomic regionse American Journal of Human Genetics 95, 39–48, July 3, 2014 45
Table 2. TEs Overlapping FHSRRs
Repeat Class
Number of Overlapping FHSRRs (FDR)
Promoters Strong Enhancers Weak Enhancers Insulators
LINE 351 (3.93 3 1060) 140 (2.47 3 1041) 643 (6.29 3 1066) 29 (>0.05)
LTR 183 (3.87 3 1046) 31 (>0.05) 479 (2.22 3 1058) 39 (1.03 3 105)
ERV1 179 (3.79 3 1076) 15 (>0.05) 381 (7.28 3 10122) 11 (>0.05)
ERVK 3 (>0.05) 15 (1.20 3 104) 95 (4.25 3 1063) 25 (3.33 3 1027)
L1 351 (5.70 3 10167) 140 (3.80 3 1082) 643 (1.17 3 10235) 29 (2.70 3 103)
HERVH-int 164 (8.46 3 10156) 12 (3.16 3 106) 343 (<1.0 3 10300) 2 (>0.05)
HERVK-int 1 (>0.05) 0 (>0.05) 11 (4.20 3 1011) 20 (5.11 3 1041)
L1HS 74 (1.13 3 1082) 38 (2.94 3 1047) 131 (5.30 3 10176) 1 (>0.05)
L1PA2 243 (2.91 3 10221) 92 (4.60 3 10101) 402 (<1.0 3 10300) 8 (1.70 3 1011)
L1PA3 25 (>0.05) 6 (>0.05) 74 (6.56 3 1032) 6 (7.01 3 104)
LTR5_Hs 2 (>0.05) 15 (5.22 3 109) 77 (1.39 3 1075) 0 (>0.05)
LTR7 13 (3.50 3 103) 1 (>0.05) 16 (1.31 3 102) 0 (>0.05)
Featured are TE classes showing significant overlap with FHSRRs active in ESCs. For each TE class and RR class, we report the number of overlapping FHSRRs. In
parentheses is the Benjamini-Hochberg FDR from the Fisher’s exact test comparing the FHSRRs overlapping the specific TEs to all TE-overlapping RRs of the
same class.and target genes rather than by a succession of point
mutations on existing sequences. This mechanism was
recently shown to be largely responsible for the evolution
of CTCF binding in mammals.13
Our approach has two main technical limitations. On
the one hand, the genomes of nonhuman mammals,
particularly primates, are at a much lower stage of
completeness than the human genome. Therefore, lack
of alignment between a human sequence and the chimp
genomemight be due to a gap in the sequence of the latter.
The fact that we used four nonhuman apes in our compar-
ison should mitigate the consequences of these technical
problems, because it is quite unlikely that sequencing
gaps happen in the same place in several genomes.
However, the possibility remains that some of the
regions that we classify as human specific are in fact shared
by humans and chimps. While this manuscript was being
prepared, the genome-wide alignments of the human
genome to a newer version of the chimp genome
(panTro4) were published in the UCSC Genome Browser.
We reasoned that if a significant fraction of our FHSRRs
were due to the preliminary status of the chimp genome,
some should disappear when these newer alignments are
used. However, none of the FHSRRs, which were originally
derived from version panTro3 of the chimp genome,
appear in the alignment with panTro4. This suggests that
at least a large majority of our FHSRRs are indeed human
specific.
The second limitation concerns the definition of RRs.
Data on chromatin modification are available only for
cell lines that are not necessarily the most suitable context
for the study of human-specific biological processes. For
example, ideally, a collection of RRs active in the human46 The American Journal of Human Genetics 95, 39–48, July 3, 2014brain would be needed for studying the regulation of
cognition-related genes and its evolution. As we have
shown, DHSs only partially fulfill this function.
Notwithstanding these limitations, we believe that we
have shown that the appearance of HSRRs had an impor-
tant role in shaping our regulatory network and thus the
phenotypic features that distinguish humans from other
animals.Supplemental Data
Supplemental Data include 3 figures and 14 tables and can be
found with this article online at http://dx.doi.org/10.1016/j.
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